Project Description

CeQur

CEO: Bradley Paddock

Sector: Medtech, Drug Delivery
Location: Horw, Switzerland
Investment Stage: Seed
Investment Status: Current
Year Invested: 2009

CeQur

CeQur is dedicated to helping people with diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company has a platform of simple, wearable, 3-day devices.

The PAQ line of products, are wearable insulin delivery devices used for 3 days at a time. Their simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. These devices allow a person to administer bolus doses of insulin with a simple click on the device. This can be done over clothing, so there is no reason to step away from friends to discreetly deliver a dose or to carry, handle and dispose of needles. CeQur has completed clinical studies evaluating PAQ devices among people with type 2 diabetes with positive improvements in A1C results.

CeQur is headquartered in Horw, Switzerland, with operations in Cardiff, United Kingdom and Marlborough, Massachusetts.

See CeQur related news here

Back to all companies

Endeavour Vision
Board Members

Robert O'Holla

Robert O’Holla

Damien Tappy

Damien Tappy

Endeavour Vision
Deal Team

Damien Tappy

Damien Tappy